Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 21, 2018; 24(11): 1228-1238
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1228
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1228
Table 1 Patient characteristics
Normal | Chronic hepatitis | Cirrhosis | HCC | |
Sex | ||||
Male | 11 (73.3 ) | 9 (36.0) | 19 (67.9) | 19 (95.0) |
Female | 4 (26.7) | 16 (64.0) | 9 (32.1) | 1 (5.0) |
Age, mean ± SD | 42.9 ± 10.2 | 49.64 ± 7.2 | 51.29 ± 9.03 | 57.1 ± 4.76 |
HCV | +ve | +ve | +ve | +ve |
Total | 15 | 25 | 28 | 20 |
- Citation: Zekri ARN, El Deeb S, Bahnassy AA, Badr AM, Abdellateif MS, Esmat G, Salama H, Mohanad M, El-dien AE, Rabah S, Abd Elkader A. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions. World J Gastroenterol 2018; 24(11): 1228-1238
- URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1228.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i11.1228